These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 23628463

  • 1. Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.
    Roudbari SA, Ansar MM, Yousefzad A.
    J Neurol Sci; 2013 Jul 15; 330(1-2):52-5. PubMed ID: 23628463
    [Abstract] [Full Text] [Related]

  • 2. Cigarette smoking and the risk of multiple sclerosis: a sibling case-control study in Isfahan, Iran.
    Maghzi AH, Etemadifar M, Heshmat-Ghahdarijani K, Moradi V, Nonahal S, Ghorbani A, Minagar A.
    Neuroepidemiology; 2011 Jul 15; 37(3-4):238-42. PubMed ID: 22156601
    [Abstract] [Full Text] [Related]

  • 3. Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
    Gava G, Bartolomei I, Costantino A, Berra M, Venturoli S, Salvi F, Meriggiola MC.
    Fertil Steril; 2014 Jul 15; 102(1):116-22. PubMed ID: 24794311
    [Abstract] [Full Text] [Related]

  • 4. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Brown MG, Kirby S, Skedgel C, Fisk JD, Murray TJ, Bhan V, Sketris IS.
    Neurology; 2007 Oct 09; 69(15):1498-507. PubMed ID: 17699802
    [Abstract] [Full Text] [Related]

  • 5. Cigarette smoking and associated risk of multiple sclerosis in the Iranian population.
    Asadollahi S, Fakhri M, Heidari K, Zandieh A, Vafaee R, Mansouri B.
    J Clin Neurosci; 2013 Dec 09; 20(12):1747-50. PubMed ID: 23972559
    [Abstract] [Full Text] [Related]

  • 6. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H, Yinshan Zhao, Devonshire V.
    Mult Scler; 2008 Apr 09; 14(3):314-24. PubMed ID: 18208898
    [Abstract] [Full Text] [Related]

  • 7. Factors associated with the risk of secondary progression in multiple sclerosis.
    Koch M, Uyttenboogaart M, van Harten A, De Keyser J.
    Mult Scler; 2008 Jul 09; 14(6):799-803. PubMed ID: 18573840
    [Abstract] [Full Text] [Related]

  • 8. Cigarette smoking and progression in multiple sclerosis.
    Koch M, van Harten A, Uyttenboogaart M, De Keyser J.
    Neurology; 2007 Oct 09; 69(15):1515-20. PubMed ID: 17923613
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Progression in familial and nonfamilial MS.
    Koch M, Uyttenboogaart M, Heerings M, Heersema D, Mostert J, De Keyser J.
    Mult Scler; 2008 Apr 09; 14(3):300-6. PubMed ID: 18208881
    [Abstract] [Full Text] [Related]

  • 11. Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive.
    Alvarez-Lafuente R, de las Heras V, García-Montojo M, Bartolomé M, Arroyo R.
    Mult Scler; 2007 Jun 09; 13(5):578-83. PubMed ID: 17548435
    [Abstract] [Full Text] [Related]

  • 12. Secondary progressive multiple sclerosis - clinical course and potential predictive factors.
    Pokryszko-Dragan A, Gruszka E, Bilińska M, Dubik-Jezierzańska M.
    Neurol Neurochir Pol; 2008 Jun 09; 42(1):6-11. PubMed ID: 18365957
    [Abstract] [Full Text] [Related]

  • 13. Early predictors of conversion to secondary progressive multiple sclerosis.
    Barzegar M, Najdaghi S, Afshari-Safavi A, Nehzat N, Mirmosayyeb O, Shaygannejad V.
    Mult Scler Relat Disord; 2021 Sep 09; 54():103115. PubMed ID: 34216997
    [Abstract] [Full Text] [Related]

  • 14. The natural history of secondary progressive multiple sclerosis.
    Koch M, Kingwell E, Rieckmann P, Tremlett H, UBC MS Clinic Neurologists.
    J Neurol Neurosurg Psychiatry; 2010 Sep 09; 81(9):1039-43. PubMed ID: 20639385
    [Abstract] [Full Text] [Related]

  • 15. Risk of secondary progressive multiple sclerosis after early worsening of disability.
    Dzau W, Sharmin S, Patti F, Izquierdo G, Eichau S, Prat A, Girard M, Duquette P, Onofrj M, Lugaresi A, Ozakbas S, Gerlach O, Boz C, Grammond P, Terzi M, Amato MP, La Spitaleri D, Ramo-Tello C, Maimone D, Cartechini E, Buzzard K, Skibina O, van der Walt A, Butzkueven H, Iuliano G, Soysal A, Kalincik T.
    J Neurol Neurosurg Psychiatry; 2023 Dec 09; 94(12):984-991. PubMed ID: 37414538
    [Abstract] [Full Text] [Related]

  • 16. [Prognostics factors of renal failure in multiple sclerosis].
    Viart L, Elalouf V, Petit J, Al Khedr A, Kristkowiak P, Saint F.
    Prog Urol; 2012 Dec 09; 22(16):1026-32. PubMed ID: 23178100
    [Abstract] [Full Text] [Related]

  • 17. Effect of Smoking Cessation on Multiple Sclerosis Prognosis.
    Ramanujam R, Hedström AK, Manouchehrinia A, Alfredsson L, Olsson T, Bottai M, Hillert J.
    JAMA Neurol; 2015 Oct 09; 72(10):1117-23. PubMed ID: 26348720
    [Abstract] [Full Text] [Related]

  • 18. Sunlight exposure and sun sensitivity associated with disability progression in multiple sclerosis.
    D'hooghe MB, Haentjens P, Nagels G, Garmyn M, De Keyser J.
    Mult Scler; 2012 Apr 09; 18(4):451-9. PubMed ID: 21952096
    [Abstract] [Full Text] [Related]

  • 19. Identification and diagnosis of Secondary Progressive Multiple Sclerosis during the clinical encounter: Results from a physician survey.
    Alvarez E, Nair KV, Gorritz M, Bartolome L, Maloney H, Ding Y, Golan T, Wade RL, Kumar R, Su W, Shah R, Russo P.
    Mult Scler Relat Disord; 2021 May 09; 50():102858. PubMed ID: 33799068
    [Abstract] [Full Text] [Related]

  • 20. A low vitamin D status at diagnosis is associated with an early conversion to secondary progressive multiple sclerosis.
    Muris AH, Rolf L, Broen K, Hupperts R, Damoiseaux J, Smolders J.
    J Steroid Biochem Mol Biol; 2016 Nov 09; 164():254-257. PubMed ID: 26598277
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.